Literature DB >> 10812392

Influence of apoptosis on the enhancement of radiotoxicity by ouabain.

F A Verheye-Dua1, L Böhm.   

Abstract

BACKGROUND: The Na+, K(+)-ATPase inhibitor ouabain enhances the toxicity of irradiation and we have previously demonstrated that the drug suppresses repair capacity. The influence of ouabain on apoptosis is not known and is examined in this study.
MATERIALS AND METHODS: Seven human cell lines of defined TP53 status were irradiated with 60Co-gamma irradiation in the presence and absence of 10(-7) M ouabain. Cell survival was determined by the clonogenic assay, apoptosis by acridine orange staining and cell cycle delays by flow cytometry.
RESULTS: The ouabain-induced enhancement of radiotoxicity, expressed as the ratio of SF2's, is independent of TP53 status and ranges from 1.1 to 2.8 depending upon cell line. Ouabain prolongs the irradiation-induced G2 delay in TP53 mutant tumor cell lines by a factor greater than 2, but not in the normal lung fibroblast L132, where the cell recovery is not altered in the presence of ouabain. Twenty hours post irradiation, ouabain enhances apoptosis induced by irradiation by factors of 1.3 to 1.7 depending on the cell line.
CONCLUSION: Ouabain preferentially enhances the radiotoxicity in tumor cells irrespective of TP53 status. In the pattern of DNA damage responses which are influenced by ouabain we show that the G2 cell cycle delay is prolonged and that early apoptosis events are upregulated in TP53 wild type and TP53 mutant cells. It is concluded that apoptosis plays a significant role in the enhancement of radiotoxicity by ouabain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10812392     DOI: 10.1007/s000660050055

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  8 in total

Review 1.  Potential roles of electrogenic ion transport and plasma membrane depolarization in apoptosis.

Authors:  R Franco; C D Bortner; J A Cidlowski
Journal:  J Membr Biol       Date:  2006-04-17       Impact factor: 1.843

2.  Ionic mechanism of ouabain-induced concurrent apoptosis and necrosis in individual cultured cortical neurons.

Authors:  Ai Ying Xiao; Ling Wei; Shuli Xia; Steven Rothman; Shan Ping Yu
Journal:  J Neurosci       Date:  2002-02-15       Impact factor: 6.167

3.  First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors.

Authors:  D S Hong; H Henary; G S Falchook; A Naing; S Fu; S Moulder; J J Wheler; A Tsimberidou; J B Durand; R Khan; P Yang; M Johansen; R A Newman; R Kurzrock
Journal:  Invest New Drugs       Date:  2014-06-13       Impact factor: 3.850

4.  Coroglaucigenin enhances the radiosensitivity of human lung cancer cells through Nrf2/ROS pathway.

Authors:  Meng Sun; Dong Pan; Yaxiong Chen; Ya Li; Kun Gao; Burong Hu
Journal:  Oncotarget       Date:  2017-05-16

Review 5.  The prince and the pauper. A tale of anticancer targeted agents.

Authors:  Alfonso Dueñas-González; Patricia García-López; Luis Alonso Herrera; Jose Luis Medina-Franco; Aurora González-Fierro; Myrna Candelaria
Journal:  Mol Cancer       Date:  2008-10-23       Impact factor: 27.401

Review 6.  Oleandrin: A cardiac glycosides with potent cytotoxicity.

Authors:  Arvind Kumar; Tanmoy De; Amrita Mishra; Arun K Mishra
Journal:  Pharmacogn Rev       Date:  2013-07

7.  Super-resolution microscopy reveals that Na+/K+-ATPase signaling protects against glucose-induced apoptosis by deactivating Bad.

Authors:  Kristoffer Bernhem; Jacopo M Fontana; Daniel Svensson; Liang Zhang; Linnéa M Nilsson; Lena Scott; Hans Blom; Hjalmar Brismar; Anita Aperia
Journal:  Cell Death Dis       Date:  2021-07-27       Impact factor: 8.469

8.  Dose and time dependence of functional impairments in rat jejunum following ionizing radiation exposure.

Authors:  Alexandra A Livanova; Arina A Fedorova; Alexander V Zavirsky; Anastasia E Bikmurzina; Igor I Krivoi; Alexander G Markov
Journal:  Physiol Rep       Date:  2021-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.